NewsRx

Search our medical news database

Finance

Product candidate gets boost from $12.8 million private placement

Published in Obesity and Diabetes Week, April 5th, 2004

MicroIslet, Inc., (MIIS) has entered into agreements for the sale of common stock for gross proceeds of approximately $12.8 million.

The purchasers include new and existing institutional, strategic, and accredited investors. The company has agreed to sell an aggregate of approximately 9.8 million shares and to issue to the investors 5-year warrants to purchase an aggregate of approximately 4.9 million shares.

Burnham Hill Partners and Duncan Capital served as nonexclusive placement agents for the offering.

The proceeds of the financing are expected to be used for working capital purposes to further development of the company's...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook